Holm-Jorgensen Rasmus - Insider Non-Derivative Transactions at Acrivon Therapeutics, Inc. (ACRV) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Aug 14, 2024, Holm-Jorgensen Rasmus's relationship to Acrivon Therapeutics, Inc. (ACRV) is Officer (Chief Financial Officer), and currently has 26,890 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ACRV insiders.

Data Source: SEC.
Holm-Jorgensen Rasmus - Insider Non-Derivative Transactions of ACRV Common Stock
Holm-Jorgensen Rasmus - Insider Non-Derivative Transactions at ACRV
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Aug 15, 2024 F -- (Common Stock) 368 7.02 26890
May 15, 2024 F -- (Common Stock) 368 8.36 27258
Feb 15, 2024 F -- (Common Stock) 434 3.4 27626
Nov 15, 2023 F -- (Common Stock) 1470 5.08 28060
Jun 17, 2023 M -- (Common Stock) 9500 3.63 29530